July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Hernan Gonzalez: This data provides new evidence of the benefit of molecular testing in well selected patients with indeterminate thyroid cytology
Nov 27, 2023, 17:11

Hernan Gonzalez: This data provides new evidence of the benefit of molecular testing in well selected patients with indeterminate thyroid cytology

Quoting Hernan Gonzalez,  on LinkedIn:

”We have just published a new prospective non-interventional study showing real-world clinic utility of ThyroidPrint. Up to 67% of patients undergoing molecular testing for indeterminate thyroid cytology were called benign (Benign Call Rate). With a minimum of 18 months of follow-up, 99% of these patients remained under surveillance. Furthermore, the post-test cancer probability in patients undergoing ThyroidPrint testing was 71% when compared to the 32% of patient that did not undergo testing. This data provides new evidence of the benefit of molecular testing in well selected patients with indeterminate thyroid cytology.”

Hernan Gonzalez: This data provides new evidence of the benefit of molecular testing in well selected patients with indeterminate thyroid cytology

For the article click here.
Source: Hernan Gonzalez/LinkedIn